HLN ($HLN) Insider Trading & Smart Money Activity

HLN · Drug Manufacturers - Specialty & Generic · Latest filing May 14, 2026

$HLN has 2 13F position changes on file.

Insider buyers (12 mo)
0
Insider sellers (12 mo)
0
Net insider $ (12 mo)
$0
Congress trades (12 mo)
0
13F moves on file
2
Analyst ratings on file
0

HLN insider buying and selling by quarter

QuarterInsider buysInsider salesCongress buys / sales13F added / cut
Q1 2026 0 0 0 / 0 0 / 0
Q2 2026 0 0 0 / 0 0 / 2
Q3 2026 0 0 0 / 0 0 / 0
Q4 2026 0 0 0 / 0 0 / 0

Insider buys and sales count open-market trades only (Form 4 codes P and S). Grants, option exercises and tax withholding are left out.

All HLN insider, congress, 13F and analyst activity

DateSourceWhoActionSharesValue / amount ΔOwn1W1M6MFilingStory
13F Dodge & Cox Reduced -5.22M sh $1.32B +4.6%+1.8% Read
13F Dodge & Cox Reduced -5.22M sh $1.37B +4.6%+1.8% —

1W / 1M / 6M = how HLN moved from the trade or filing date.

Institutions moving HLN (13F)

Frequently asked questions

Which institutions changed their HLN positions?

Recent 13F filers moving the stock include Dodge & Cox.

Other drug manufacturers - specialty & generic stocks

Data comes from public SEC Form 4 and 13F filings and STOCK Act disclosures. Dates are the trade or filing date reported. This page is for research only and is not investment advice.

Get trade alerts by text